GSF is pleased to announce that Francois Nader, MD, MBA will be a special guest at our upcoming Gala Dinner on November 5 in Boston. He will address the development of the Moderna vaccine against COVID-19. The vaccine enabled GSF to return to the field for medical missions.
Dr, Nader currently serves as chair of Talaris Therapeutics (TALS), Benevolent AI (BAI) and Neurvati Neurosciences. He also serves as board director of Moderna (MRNA) and RING Therapeutics and as senior advisor to Blackstone Life Sciences.